BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2807152)

  • 1. Prognostic factors in medullary thyroid carcinomas.
    Schröder S; Dralle H
    Horm Metab Res Suppl; 1989; 21():26-8. PubMed ID: 2807152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].
    Schröder S; Dralle H; Bay V; Böcker W
    Acta Med Austriaca; 1989; 16(1):2-5. PubMed ID: 2711816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
    Schröder S
    Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.
    el-Naggar AK; Ordonez NG; McLemore D; Schultz P; Hickey RC; Samaan N
    Surgery; 1990 Dec; 108(6):981-5. PubMed ID: 2247844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid carcinoma: prognostic factors.
    Riddell DA; Lampe HB; Cramer H; Troster M
    J Otolaryngol; 1993 Jun; 22(3):180-3. PubMed ID: 7690409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA cytophotometry of oxyphilic thyroid tumors].
    Pilch H; Back W; Winter J
    Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.
    Schröder S; Schwarz W; Rehpenning W; Dralle H; Bay V; Böcker W
    J Cancer Res Clin Oncol; 1988; 114(3):291-6. PubMed ID: 3260237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
    Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA
    Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Image analysis DNA cytometry in medullary thyroid gland cancer. Comparison with histomorphologic parameters and prognostic effect].
    Böttger T; Potratz D; Gabbert H; Schernus B; Stöckle M; Klupp J; Junginger T
    Chirurg; 1993 Feb; 64(2):122-9. PubMed ID: 8096455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of protein p53: the marker of low neoplastic cell differentiation in thyroid carcinoma].
    Szybiński P; Nowak W; Stachura J; Nowak K; Przybylik-Mazurek E; Buziak-Bereza M
    Wiad Lek; 2001; 54 Suppl 1():88-94. PubMed ID: 12182067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
    Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
    Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.
    Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F
    Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histological differences in anaplastic thyroid carcinoma.
    Rodriguez JM; Piñero A; Ortiz S; Moreno A; Sola J; Soria T; Robles R; Parrilla P
    Eur J Surg; 2000 Jan; 166(1):34-8. PubMed ID: 10688214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan expression in differentiated thyroid carcinoma.
    Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM
    J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.